SEC Form D filing

Liminatus Pharma, Inc.

Biotech · Seed · Regulation D 506(b) · CA · Filed June 18, 2026

Websiteliminatuspharma.com

Offering amount: $1.9M
Exemption: Reg D 506(b)
Issuer state: CA
Filing date: June 18, 2026
Signature date: June 18, 2026
CIK: 0001971387

Summary

Auto-generated

The issuer is a pharmaceutical company, indicating a biotechnology vertical. It raised approximately $1.86 million under a Rule 506(b) exemption filed on June 18, 2026.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.